US Patent 8900252 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
Patent 8900252 was granted and assigned to Neotract on December, 2014 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 15, 2013
Date of Patent
December 2, 2014
Patent Applicant
Patent Application Number
13844020
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8900252 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.